The SARS outbreak of the early 2000s that infected thousands worldwide and killed many was a learning moment for Beijing on how dangerous such viruses can be, says physician-scientist and author Dr. Steven Quay.
“They began to see these as potential bioweapons,” Dr. Quay, previously on the faculty of Stanford University’s School of Medicine and now CEO of Atossa Therapeutics, told The Epoch Times.